These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 66503)

  • 1. Prostaglandin and damage to ductus arteriosus.
    Moulaert AJ; Gittenberger AC; Harinck E
    Lancet; 1977 Mar; 1(8013):703-4. PubMed ID: 66503
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological manipulation of the ductus arteriosus.
    Silove ED
    Arch Dis Child; 1986 Sep; 61(9):827-9. PubMed ID: 3767410
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of prostaglandin E1 and E2 in the management of neonatal heart disease.
    Olley PM; Coceani F; Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():345-53. PubMed ID: 645511
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.
    Gittenberger-de Groot AC; Moulaert AJ; Harinck E; Becker AE
    Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care of the infant with ductus-dependent congenital heart disease receiving prostaglandin E1.
    Stachura L
    Issues Compr Pediatr Nurs; 1984; 7(4-5):203-15. PubMed ID: 6569057
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.
    Freed MD; Heymann MA; Lewis AB; Roehl SL; Kensey RC
    Circulation; 1981 Nov; 64(5):899-905. PubMed ID: 7285305
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of prostaglandins and blockers of prostaglandin synthesis on the ductus arteriosus: animal and human studies.
    Heymann MA; Rudolph AM
    Adv Prostaglandin Thromboxane Res; 1978; 4():363-72. PubMed ID: 645512
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic use of prostaglandin E1 in infant with congenital heart disease.
    Heymann MA
    Am Heart J; 1981 Jun; 101(6):837-43. PubMed ID: 7234660
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():383-5. PubMed ID: 645513
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Medical manipulation of the ductus arteriosus.
    Christensen NC; Fabricus J
    Lancet; 1975 Aug; 2(7931):406-7. PubMed ID: 51207
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
    Heymann MA; Clyman RI
    Pharmacotherapy; 1982; 2(3):148-55. PubMed ID: 6763200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy.
    Silver MM; Freedom RM; Silver MD; Olley PM
    Hum Pathol; 1981 Dec; 12(12):1123-36. PubMed ID: 7199511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS; Nihill MR; Titus JL
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of prostaglandin in heart abnormalities with needed patency of the arterial canal (clinical and histological study)].
    Moulaert A; Gittenberger-De Groot A; Harinck E
    Arch Fr Pediatr; 1978; 35(7):717-25. PubMed ID: 736728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
    Olley PM; Coceani F; Bodach E
    Circulation; 1976 Apr; 53(4):728-31. PubMed ID: 56243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 infusion: successful initial treatment.
    Linday L; Levin AR; Reitman M; Engle MA
    N Y State J Med; 1981 Feb; 81(2):218-21. PubMed ID: 6936640
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular therapy in the newborn.
    Sandor GG
    Clin Invest Med; 1985; 8(4):360-7. PubMed ID: 3907921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.